Rare diseases
Investigational molecules
Locations
Study on HIV-1 Treatment for Patients New to Therapy: Comparing Doravirine/Islatravir with a Drug Combination
FranceStudy on Switching HIV Treatment to Doravirine and Islatravir for Patients with HIV-1
FrancePhase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus
BulgariaStudy of MK-8527 taken once monthly compared to emtricitabine/tenofovir taken daily for HIV-1 prevention
FranceStudy on Lenacapavir for HIV Prevention in Individuals at Risk of HIV Infection
FranceStudy on the Safety and Effectiveness of Emtricitabine and Tenofovir Alafenamide for HIV-1 Prevention in Men and Transgender Women at Risk
AustriaStudy of Weekly Oral GS-1720 and GS-4182 for Untreated HIV-1 Patients
GermanyStudy on HIV Treatment Interruption in Children with Perinatal HIV Using Lamivudine and Drug Combination
ItalyStudy Comparing Weekly Islatravir/Lenacapavir Regimen to Standard Care in HIV Patients with Controlled Viral Load
GermanyStudy on Dolutegravir and Lamivudine for Maintaining Viral Control in Children with HIV Aged 2 to Under 15 Years
SpainStudy to Compare Weekly Islatravir/Lenacapavir with Bictegravir/Emtricitabine/Tenofovir in People with HIV-1 Who Are Virologically Suppressed
FranceStudy on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
